IOL CHEMICALS & PHARM. | MANGALAM DRUGS | IOL CHEMICALS & PHARM./ MANGALAM DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -9.4 | - | View Chart |
P/BV | x | 1.6 | 1.0 | 148.4% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. MANGALAM DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
MANGALAM DRUGS Mar-23 |
IOL CHEMICALS & PHARM./ MANGALAM DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 173 | 310.9% | |
Low | Rs | 272 | 95 | 286.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 235.2 | 160.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.8 | 2,954.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.7 | 407.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 96.0 | 267.5% | |
Shares outstanding (eoy) | m | 58.71 | 15.83 | 370.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.6 | 188.2% | |
Avg P/E ratio | x | 17.1 | 166.8 | 10.2% | |
P/CF ratio (eoy) | x | 12.8 | 17.3 | 74.2% | |
Price / Book Value ratio | x | 1.6 | 1.4 | 113.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,118 | 1,120.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 346 | 486.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 3,723 | 595.6% | |
Other income | Rs m | 256 | 4 | 5,873.9% | |
Total revenues | Rs m | 22,427 | 3,727 | 601.8% | |
Gross profit | Rs m | 2,257 | 255 | 884.4% | |
Depreciation | Rs m | 462 | 110 | 420.1% | |
Interest | Rs m | 165 | 128 | 129.2% | |
Profit before tax | Rs m | 1,887 | 22 | 8,520.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 9 | 5,244.7% | |
Profit after tax | Rs m | 1,391 | 13 | 10,955.9% | |
Gross profit margin | % | 10.2 | 6.9 | 148.5% | |
Effective tax rate | % | 26.2 | 42.6 | 61.6% | |
Net profit margin | % | 6.3 | 0.3 | 1,839.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,066 | 467.9% | |
Current liabilities | Rs m | 5,025 | 1,654 | 303.9% | |
Net working cap to sales | % | 20.9 | 11.1 | 189.0% | |
Current ratio | x | 1.9 | 1.2 | 154.0% | |
Inventory Days | Days | 43 | 1 | 3,699.0% | |
Debtors Days | Days | 8 | 456 | 1.8% | |
Net fixed assets | Rs m | 11,017 | 1,530 | 719.9% | |
Share capital | Rs m | 587 | 158 | 370.9% | |
"Free" reserves | Rs m | 14,490 | 1,361 | 1,064.4% | |
Net worth | Rs m | 15,077 | 1,520 | 992.2% | |
Long term debt | Rs m | 0 | 188 | 0.0% | |
Total assets | Rs m | 20,684 | 3,596 | 575.1% | |
Interest coverage | x | 12.5 | 1.2 | 1,061.2% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.0 | 103.6% | |
Return on assets | % | 7.5 | 3.9 | 193.0% | |
Return on equity | % | 9.2 | 0.8 | 1,104.2% | |
Return on capital | % | 13.6 | 8.8 | 155.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 25.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 958 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,078 | 550.0% | |
Fx outflow | Rs m | 6,052 | 978 | 618.8% | |
Net fx | Rs m | -122 | 100 | -121.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 395 | 309.4% | |
From Investments | Rs m | -1,200 | -222 | 541.2% | |
From Financial Activity | Rs m | -41 | -166 | 24.7% | |
Net Cashflow | Rs m | -18 | 7 | -250.7% |
Indian Promoters | % | 48.2 | 50.3 | 95.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.3 | 653.8% | |
FIIs | % | 1.4 | 0.3 | 538.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.7 | 104.3% | |
Shareholders | 130,003 | 19,173 | 678.1% | ||
Pledged promoter(s) holding | % | 0.0 | 17.6 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | MANGALAM DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -0.85% | 0.45% |
1-Month | 5.76% | 3.70% | 2.55% |
1-Year | -2.63% | -12.29% | 56.14% |
3-Year CAGR | -12.88% | -12.70% | 15.22% |
5-Year CAGR | 16.82% | 13.03% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the MANGALAM DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of MANGALAM DRUGS the stake stands at 50.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of MANGALAM DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
MANGALAM DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of MANGALAM DRUGS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.